← Back to headlines
Novartis to Acquire Experimental Breast Cancer Drug in $3 Billion Deal
Pharmaceutical giant Novartis is reportedly set to acquire an experimental breast cancer drug in a deal valued at up to $3 billion, expanding its oncology pipeline.
21 Mar, 09:24 — 21 Mar, 09:24
Sources
Showing 1 of 1 sources
.webp%3Fwidth%3D1200%26auto%3Dwebp%26trim%3D223%252C0%252C225%252C0&w=828&q=75&output=webp&default=1)